| 1 |
35434002 | A case report of Maturity-onset diabetes of the young 12: large fragment deletion in ABCC8 gene with literature review. | 2022 Mar |
1 |
| 2 |
35512857 | Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparations. | 2022 Jun |
1 |
| 3 |
35571731 | Effects of Glimepiride Combined with Recombinant Human Insulin Injection on Serum IGF-1, VEGF and TRACP-5b Oxidative Stress Levels in Patients with Type 2 Diabetes Mellitus. | 2022 |
2 |
| 4 |
33665047 | Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience. | 2021 Jan 30 |
1 |
| 5 |
31926091 | The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus. | 2020 Jan 11 |
1 |
| 6 |
32602682 | Clinical Utilization Pattern of Multiple Strengths of Glimepiride and Metformin Fixed Dose Combinations in Indian Type 2 Diabetes Patients. | 2020 Jul |
1 |
| 7 |
33219735 | PPARγ agonists delay age-associated metabolic disease and extend longevity. | 2020 Nov |
1 |
| 8 |
30641691 | Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients. | 2019 Jan - Feb |
3 |
| 9 |
31108137 | Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis. | 2019 Jun |
2 |
| 10 |
31292311 | The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes. | 2019 Oct 28 |
2 |
| 11 |
29469970 | Glimepiride treatment in a patient with type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene. | 2018 Sep |
1 |
| 12 |
27592478 | Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients. | 2016 Jul |
1 |
| 13 |
24889731 | Different effects of two dipeptidyl peptidase-4 inhibitors and glimepiride on β-cell function in a newly designed two-step hyperglycemic clamp. | 2015 Mar |
1 |
| 14 |
26548081 | Interaction of mouse intestinal P-glycoprotein with oral antidiabetic drugs and its inhibitors. | 2015 Sep |
1 |
| 15 |
24485398 | Adding glimepiride to insulin+metformin in type 2 diabetes of more than 10 years' duration--a randomised, double-blind, placebo-controlled, cross-over study. | 2014 Feb |
3 |
| 16 |
24874591 | Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients. | 2014 Jul |
2 |
| 17 |
23384119 | Effect of vildagliptin compared to glimepiride on postprandial proinsulin processing in the β cell of patients with type 2 diabetes mellitus. | 2013 Jun |
1 |
| 18 |
23028231 | Glimepiride: evidence-based facts, trends, and observations (GIFTS). [corrected]. | 2012 |
1 |
| 19 |
21067837 | Contribution of glimepiride to basal-prandial insulin therapy in patients with type 2 diabetes. | 2011 Feb |
2 |
| 20 |
21378174 | Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia. | 2011 Apr |
1 |
| 21 |
21645507 | Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients. | 2011 Sep |
2 |
| 22 |
20045213 | Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus. | 2010 Apr |
1 |
| 23 |
20166804 | Novel glimepiride derivatives with potential as double-edged swords against type II diabetes. | 2010 Feb |
3 |
| 24 |
20865534 | Modeling of ATP-sensitive inward rectifier potassium channel 11 and inhibition mechanism of the natural ligand, ellagic acid, using molecular docking. | 2010 |
2 |
| 25 |
21426008 | Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription. | 2010 Apr |
1 |
| 26 |
19394976 | Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. | 2009 Aug |
2 |
| 27 |
19692134 | Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride. | 2009 Oct |
2 |
| 28 |
20069052 | Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations. | 2009 |
1 |
| 29 |
18378631 | Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. | 2008 Apr 2 |
1 |
| 30 |
18831351 | Relationship between plasma leptin and plasma insulin levels in type-2 diabetic patients before and after treatment with glibenclamide and glimepiride. | 2008 Jan-Mar |
1 |
| 31 |
17594391 | Pioglitazone plus glimepiride: a promising alternative in metabolic control. | 2007 Jun |
1 |
| 32 |
17728849 | Pioglitazone hydrochloride/glimepiride. | 2007 Jul |
1 |
| 33 |
18078023 | A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes. | 2007 |
1 |
| 34 |
16324923 | Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. | 2006 Jan |
1 |
| 35 |
16406190 | Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes. | 2006 Jun |
2 |
| 36 |
16538000 | Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis. | 2006 Feb |
2 |
| 37 |
16810145 | Diabetes mellitus: complications and therapeutics. | 2006 Jul |
1 |
| 38 |
15660744 | Insulin resistance determines efficacy of glimepiride in Type 2 diabetic patients not well controlled by diet alone. | 2005 Feb |
1 |
| 39 |
15677775 | Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. | 2005 Feb |
1 |
| 40 |
15694373 | Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes. | 2005 Mar 11 |
3 |
| 41 |
15936468 | Efficacy of glimepiride in Japanese type 2 diabetic subjects. | 2005 Jun |
1 |
| 42 |
16284434 | Efficacy of glimepiride in patients with poorly controlled insulin-treated type 2 diabetes mellitus. | 2005 Oct |
1 |
| 43 |
16555581 | Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. | 2005 Nov |
1 |
| 44 |
14709397 | Protective actions of gliclazide on high insulin-enhanced neutrophil-endothelial cell interactions through inhibition of mitogen activated protein kinase and protein kinase C pathways. | 2004 Jan |
1 |
| 45 |
15133755 | The antidiabetic agent, gliclazide, reduces high insulin-enhanced neutrophil-transendothelial migration through direct effects on the endothelium. | 2004 May-Jun |
1 |
| 46 |
15162895 | Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride. | 2004 May |
4 |
| 47 |
15220018 | Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. | 2004 May |
1 |
| 48 |
15531188 | The role of glimepiride in the effective management of Type 2 diabetes. | 2004 Nov-Dec |
2 |
| 49 |
15563963 | Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide. | 2004 Dec |
2 |
| 50 |
15645955 | Use of glimepiride and insulin sensitizers in the treatment of type 2 diabetes--a study in Indians. | 2004 Jun |
1 |